At home between cultures — which is exactly the bridge I bring to global teams.

For eighteen years I've made my home in Germany, while staying deeply rooted in Poland. Moving between those two worlds taught me early what it means to translate — not just language, but context, expectation, and intent. It is the same skill I now bring to global drug-development teams.

I started my career in a biotech start-up, leading preclinical antisense programs. The work was hands-on, fast, and demanded a scientist's precision alongside a builder's pragmatism.

From there I moved into clinical research, beginning in Phase I. Step by step, program by program, I grew into leading a strategically prioritized global Phase III trial running across 34 countries.

Today I have 15+ years of experience leading international drug-development projects, in start-ups and in large pharma. My credentials — DVM, M.Sc. Eng., MBA — reflect a deliberate combination of scientific depth and business acumen.

What clients consistently tell me is that I bring more than project management. I bring clarity to ambiguous moments, structure to programs that have lost theirs, and decision-ready transparency to executives and boards.

I work best with sponsors who care about doing the work properly: rigorous science, disciplined execution, honest conversations with vendors, regulators and KOLs.

I am called in when projects stall, when complexity grows faster than the organisation around it, or when a critical program simply has to land — and land well.

When your project is losing direction, time or budget, I restore clarity, control and delivery — so innovative therapies reach patients faster.